Log in

Relevant bibliographies by topics / Myeloproliferative / Books

To see the other types of publications on this topic, follow the link: Myeloproliferative.

Books on the topic 'Myeloproliferative'

Author: Grafiati

Published: 10 March 2023

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Myeloproliferative.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Melo, Junia V., and John M. Goldman. Myeloproliferative Disorders. Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/978-3-540-34506-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Verstovsek, Srdan, and Ayalew Tefferi, eds. Myeloproliferative Neoplasms. Humana Press, 2011. http://dx.doi.org/10.1007/978-1-60761-266-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Barbui, Tiziano, and Ayalew Tefferi, eds. Myeloproliferative Neoplasms. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-24989-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Richard, Green A., and Pearson Tom C, eds. Myeloproliferative disorders. Baillière Tindall, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Mesa, Ruben A., and Claire Harrison, eds. Managing Myeloproliferative Neoplasms. Cambridge University Press, 2016. http://dx.doi.org/10.1017/cbo9781316017852.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Petrides, Petro E., and Heike L. Pahl, eds. Molecular Basis of Chronic Myeloproliferative Disorders. Springer Berlin Heidelberg, 2004. http://dx.doi.org/10.1007/978-3-642-18738-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Barbui, Tiziano. Myeloproliferative Neoplasms: Critical Concepts and Management. Springer Berlin Heidelberg, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Parker, James N., and Philip M. Parker. The official patient's sourcebook on myeloproliferative disorders. Icon Health Publications, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Leukemia & Lymphoma Society of America. Coping: Support for people living with leukemia, lymphoma or myeloma. Leukemia & Lymphoma Society, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

D, Zanjani Esmail, Tavassoli Mehdi 1933-, Ascensao Joao L, and Wasserman Louis R, eds. Regulation of erythropoiesis. PMA Pub. Corp., 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Dallinger, Kenneth James Charles. Myeloproliferative disorders: The effect on (1) fibrinogen turnover, (2) prostanoid metabolism. University of Birmingham, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

H, Robinson Stephen, and Reich Paul Richard, eds. Hematology: Pathophysiologic basis for clinical practice. 3rd ed. Little, Brown, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

McCormick, Thomas Ronald. A study of Beta-2-Microglobulin in myeloproliferative, lymphoproliferative and renal disorders. The Author], 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Löfvenberg, Eva. Chronic myeloproliferative disease with thrombocytosis: A clinical, morphological and cytogenetic study with emphasis on effects of hydroxyurea therapy. University of Umeaa, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Bergamo Spring Conferences on Haematology (1st 1987). Cellular blood components in haemostasis and thrombosis: Implications from myeloproliferative disorders : proceedings of the Conference held in Bergamo on May 7-8, 1987. Libbey, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

G, Abraham Nader, and Symposium on the Molecular Biology of Hematopoiesis (11th 1998 : Bormio, Italy), eds. Molecular biology of hematopoiesis 6. Kluwer Academic/Plenum Publishers, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

N, Emmons Foxwell, ed. Atlas of differential diagnosis in neoplastic hematopathology. 2nd ed. Informa Healthcare, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Wehrle, Julius. Genomweite Analyse der Regulation durch NF-E2 in hämatopoetischen Stammzellen im Kontext myeloproliferativer Neoplasien. s.n.], 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Arnold, Christian Richard. Der Transkriptionsfaktor NF-E2 und seine Rolle in der Pathogenese der Thrombozytose myeloproliferativer Neoplasien. s.n.], 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Melo, J. V., and J. Goldman. Myeloproliferative Disorders. Springer, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Collins, Graham, and Chris Bunch. Myeloproliferative disorders. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0291.

Full text

Abstract:

Myeloproliferative disorders (also called myeloproliferative neoplasms) can be defined as clonal haematopoietic disorders resulting in excess production of one or more blood cell lineage. The four main conditions are primary polycythaemia, which is characterized by excess red-cell production; essential thrombocythaemia, which is characterized by excess platelet production; chronic myeloid leukaemia, which is characterized by excess granulocyte production; and myelofibrosis, which is characterized by excess megakaryocyte proliferation, which results in a reactive fibroblast proliferation causin

APA, Harvard, Vancouver, ISO, and other styles

22

Provan, Drew, Trevor Baglin, Inderjeet Dokal, and Johannes de Vos. Myeloproliferative neoplasms. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199683307.003.0007.

Full text

Abstract:

Myeloproliferative neoplasms (MPNs) - Pathogenesis of the MPNs - Polycythaemia vera (PV) - Natural history of PV - Management of PV - Secondary erythrocytosis - Relative erythrocytosis - Idiopathic erythrocytosis - Essential thrombocythaemia - Reactive thrombocytosis - Primary myelofibrosis - Chronic neutrophilic leukaemia - Eosinophilic syndromes and neoplasms - Mastocytosis (mast cell disease) - Systemic mastocytosis - MPN—unclassifiable

APA, Harvard, Vancouver, ISO, and other styles

23

Provan, Drew, Trevor Baglin, Inderjeet Dokal, Johannes de Vos, and Mammit Kaur. Myeloproliferative neoplasms. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199683307.003.0007_update_001.

Full text

Abstract:

Myeloproliferative neoplasms (MPNs) - Pathogenesis of the MPNs - Polycythaemia vera (PV) - Natural history of PV - Management of PV - Secondary erythrocytosis - Relative erythrocytosis - Idiopathic erythrocytosis - Essential thrombocythaemia - Reactive thrombocytosis - Primary myelofibrosis - Chronic neutrophilic leukaemia - Eosinophilic syndromes and neoplasms - Mastocytosis (mast cell disease) - Systemic mastocytosis - MPN—unclassifiable

APA, Harvard, Vancouver, ISO, and other styles

24

Silver, Richard T., and Ayalew Tefferi, eds. Myeloproliferative Disorders. CRC Press, 2007. http://dx.doi.org/10.3109/9781420061635.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Tefferi, Ayalew, and Richard T. Silver. Myeloproliferative Disorders. Taylor & Francis Group, 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Goldman, John M., and Tariq Mughal. Chronic Myeloproliferative Disorders. Taylor & Francis Group, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Mughal, Tariq, and John M. Goldman, eds. Chronic Myeloproliferative Disorders. CRC Press, 2013. http://dx.doi.org/10.3109/9780203091616.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

(Editor), Tariq Mughal, and John M. Goldman (Editor), eds. Chronic Myeloproliferative Disorders. Informa Healthcare, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Goldman, John M., and Tariq Mughal. Chronic Myeloproliferative Disorders. Taylor & Francis Group, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Chronic Myeloproliferative Disorders. Karger, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

Myeloproliferative Disorders (Hematologic Malignancies). Springer, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

(Editor), J. V. Melo, and J. M. Goldman (Editor), eds. Myeloproliferative Disorders (Hematologic Malignancies). Springer, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Bain, Barbara J. Chronic Myeloproliferative Disorders: Cytogenetic and Molecular Genetic Abnormalities (Chronic Myeloproliferative Disorders). S. Karger Publishers (USA), 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

Mughal, Tariq I., and Tiziano Barbui. Oxford Specialist Handbook: Myeloproliferative Neoplasms. Oxford University Press, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

Mughal, Tariq I., and Tiziano Barbui, eds. Oxford Specialist Handbook: Myeloproliferative Neoplasms. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198744214.001.0001.

Full text

Abstract:

Our understanding of myeloproliferative neoplasms (MPN) disorders, a group of clonal haematological malignancies characterized by excessive accumulation of one or more myeloid cell lineages, has grown considerably over the past four decades. Even more importantly is the speed at which many of these findings were translated to accord survival benefits to our patients with MPN, in particular chronic myeloid leukaemia (CML), polycythaemia vera (PV), essential thrombocythaemia (ET), and primary myelofibrosis (PMF). This text offers a detailed evidence-based guide to MPN in an easily accessible for

APA, Harvard, Vancouver, ISO, and other styles

36

Contemporary Management of Myeloproliferative Neoplasms. Jaypee Brothers Medical Publishers (P) Ltd., 2015. http://dx.doi.org/10.5005/jp/books/12391.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Tefferi, Ayalew, and Srdan Verstovsek. Myeloproliferative Neoplasms: Biology and Therapy. Humana, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

Myeloproliferative disorders: Biology and management. Informa Healthcare, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

Tefferi, Ayalew, and Richard T. Silver. Myeloproliferative Disorders: Biology and Management. Taylor & Francis Group, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

Tefferi, Ayalew, and Richard T. Silver. Myeloproliferative Disorders: Biology and Management. Taylor & Francis Group, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

Tefferi, Ayalew, and Richard T. Silver. Myeloproliferative Disorders: Biology and Management. Taylor & Francis Group, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Bennett, John M. Myeloproliferative Disorders: Biology and Management. Informa Healthcare, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Tefferi, Ayalew, and Srdan Verstovsek. Myeloproliferative Neoplasms: Biology and Therapy. Humana Press, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

Stein, Brady L., and Brandon J. McMahon. Contemporary Management of Myeloproliferative Neoplasms. Jaypee Brothers Medical Publishers, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

Tefferi, Ayalew, and Richard T. Silver. Myeloproliferative Disorders: Biology and Management. Taylor & Francis Group, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Myeloproliferative neoplasms: Biology and therapy. Humana Press, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

47

Molecular Basis of Chronic Myeloproliferative Disorders. Island Press, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Wasserman, Louis R., Paul D. Berk, and Nathaniel I. Berlin. Polycythemia Vera and the Myeloproliferative Disorders. Saunders, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

49

Myeloproliferative Neoplasms Critical Concepts And Management. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

50

Petrides, P. E. Molecular Basis of Chronic Myeloproliferative Disorders. Springer, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!